PRP therapy for hair loss is one of the most commonly recommended non-surgical treatments in India, and one of the most inconsistently delivered. Patients are told they need three sessions. Others are told six. Some are sold packages of twelve. A few are told a single session will produce visible results. None of these numbers is universally correct, and the variation reflects the absence of a standardised, clinically grounded protocol rather than genuine disagreement about a complex biological question.
The honest answer to how many PRP sessions a patient needs is that it depends on four specific factors: the type and stage of hair loss, the patient's biological response to PRP, what other treatments are being used alongside it, and what outcome the patient is trying to achieve. This blog explains each of these factors and gives Indian patients a realistic framework for evaluating any PRP protocol they are offered.
If you are currently on a PRP course and are unsure whether the number of sessions you have been prescribed is appropriate for your clinical situation, a consultation at RECOMB gives you a specific assessment.
Book a PRP Assessment and Treatment Review at RECOMB, Surat →
WhatsApp: +91 7624008000 | www.recombhair.com
What PRP Actually Does and What It Cannot Do
Before addressing session numbers, setting accurate expectations about what PRP achieves is essential, because the number of sessions that is enough depends entirely on what enough means for a specific patient with a specific diagnosis.
PRP delivers concentrated platelets containing growth factors to the follicular environment through scalp injection. These growth factors, primarily platelet-derived growth factor, vascular endothelial growth factor, and epidermal growth factor, stimulate follicle health, reduce perifollicular inflammation, support the anagen growth phase, and improve scalp microcirculation. The net clinical effect in patients with early to moderate androgenetic alopecia is reduced shedding, improved hair shaft diameter, and modest density improvement in follicles that are miniaturising but still active.
PRP cannot restore follicles that have completely miniaturised. It cannot regrow hair in visibly bald areas. It cannot replace surgical restoration for patients who need it, and it cannot substitute for finasteride and minoxidil in patients with confirmed androgenetic alopecia who have no medical contraindication to these medications. Understanding these limits is as important as understanding the treatment itself, because patients who expect PRP to deliver results it cannot achieve will be dissatisfied regardless of how many sessions they complete.
The Evidence Base for PRP Session Numbers
The clinical literature on PRP for androgenetic alopecia consistently shows that a minimum of three to four sessions is required to produce a measurable clinical response. Single-session PRP does not produce lasting benefit because the growth factor environment created by one session dissipates within weeks and does not produce the sustained follicle-level changes that require repeated stimulation to establish.
Most well-designed studies showing meaningful clinical improvement use a protocol of three to six sessions spaced two to four weeks apart as the initial course. Trichoscopy or phototrichogram assessments at the end of this initial course typically show measurable improvement in hair density, shaft diameter, and shedding rate compared to baseline in responding patients.
Maintenance sessions after the initial course are required to sustain the benefit. The growth factor environment established during the initial course diminishes over months without reinforcement. Most evidence supports maintenance intervals of three to six months, with the specific interval determined by the patient's clinical response and rate of benefit deterioration between sessions.
There is no evidence that session numbers beyond six in the initial course produce proportionally greater benefit than a well-spaced four to six session protocol. Clinics that recommend twelve or more sessions in the initial phase without clinical justification are extending the course beyond what evidence supports, which benefits the clinic's revenue more than the patient's scalp.
Factor 1: Type and Stage of Hair Loss
The most important determinant of how many PRP sessions are appropriate is the diagnosis and its stage.
For early androgenetic alopecia, Norwood Grade 1 to 3 in men or early Ludwig in women, where a significant proportion of follicles are miniaturising but still active, PRP has its greatest clinical impact. An initial course of four sessions spaced three to four weeks apart, followed by maintenance every four to six months, is typically sufficient to produce and sustain meaningful benefit in this patient profile. The active follicle population is large enough to respond to growth factor stimulation, and the benefit of each session is more substantial when there are more viable follicles to support.
For moderate androgenetic alopecia, Grade 3 to 4, the proportion of miniaturised follicles is higher and the potential for PRP to produce significant density improvement is lower. An initial course of four to six sessions remains appropriate, but the expected outcome is stabilisation and modest improvement rather than dramatic density increase. Maintenance is equally important in this group because the underlying progression continues without it.
For advanced androgenetic alopecia, Grade 5 or above, PRP as a standalone treatment produces minimal clinical benefit because most follicles in the affected zones have already miniaturised beyond the point of response to growth factor stimulation. In these patients, PRP may be appropriate as a post-surgical support treatment rather than as primary management, and the session number and timing should reflect this specific role.
For telogen effluvium without concurrent androgenetic alopecia, PRP may not be indicated at all. The primary intervention is addressing the triggering cause, and follicle health typically recovers without biological support once the trigger is removed. Prescribing a course of PRP for telogen effluvium reflects either a diagnostic error or a commercial decision rather than a clinical one.
Factor 2: Biological Response to PRP
Patients respond to PRP with significant individual variation. The platelet count and growth factor concentration in a patient's own blood, the sensitivity of their follicles to growth factor signalling, and the baseline inflammatory status of their scalp all affect how strongly they respond to each session.
A patient who shows measurable improvement in trichoscopy findings after three sessions, with visibly reduced shedding and improved hair shaft diameter, is a strong responder for whom a four-session initial course and quarterly maintenance is well-supported. A patient who shows minimal change after four sessions may be a poor responder for whom continuing PRP beyond this point produces limited additional benefit and GFC therapy may be a more effective alternative.
This is why trichoscopy assessment after the initial course is clinically important. Continuing PRP indefinitely without assessing whether the patient is responding is commercially convenient but not clinically defensible. The response to the initial course should guide both the decision to continue and the decision about whether a different biological treatment would serve the patient better.
Factor 3: What Other Treatments Are Being Used Alongside PRP
PRP produces better outcomes when combined with finasteride and minoxidil than when used alone. The combination addresses complementary mechanisms: finasteride reduces the DHT signal driving ongoing miniaturisation, minoxidil extends the anagen phase through improved circulation, and PRP delivers biological growth factor support at the follicular level.
When this combination is in place, PRP sessions reinforce a follicular environment that is already being optimised by medical management. The response tends to be stronger and more sustained, and the maintenance interval can sometimes be extended compared to PRP used in isolation.
When PRP is used without any concurrent medical management in a patient with active androgenetic alopecia, the growth factor benefit of each session works against the ongoing DHT-driven miniaturisation that is not being addressed. The patient may notice improvement between sessions and deterioration in the weeks before the next one, cycling rather than progressing. This pattern suggests that the PRP is providing temporary benefit that medical management would sustain.
In this situation, the correct response is not to increase PRP session frequency. It is to introduce appropriate medical management alongside PRP so each session's benefit is preserved and built upon rather than partially reversed before the next.
Factor 4: What the Patient Is Trying to Achieve
A patient using PRP to slow the progression of early loss that is being actively managed with finasteride and minoxidil has different session requirements from a patient using PRP post-transplant to support graft growth and protect surrounding native hair, who in turn has different requirements from a patient using PRP as a standalone treatment because they cannot take systemic medication.
Each of these clinical scenarios has a different appropriate session number and maintenance protocol. A session number that is correct for one scenario is likely incorrect for another. Any PRP protocol that does not begin with a clear statement of what clinical outcome it is designed to achieve and how the session number follows from that objective has not been properly planned.
Practical Session Framework for Indian Patients
Based on the clinical evidence and the factors described above, the following represents a realistic session framework for the most common patient profiles presenting in India.
For early loss, Norwood Grade 1 to 3, on concurrent finasteride and minoxidil: initial course of four sessions spaced three to four weeks apart, followed by trichoscopy assessment, followed by maintenance every four to six months if responding.
For moderate loss, Norwood Grade 3 to 4, on concurrent medical management: initial course of four to six sessions spaced three to four weeks apart, trichoscopy assessment, maintenance every three to four months given higher ongoing progression risk.
Post-hair transplant support: three to four sessions beginning at the three-month post-operative mark, spaced four weeks apart, with maintenance every four to six months alongside continued medical management.
Without concurrent medical management in a patient who cannot take systemic finasteride: initial course of six sessions spaced three weeks apart to establish a stronger biological foundation without the supporting hormonal management, with maintenance every three months.
In each case the session number should be treated as a starting framework confirmed or adjusted by the trichoscopy response at the end of the initial course, not as a fixed commercial protocol.
RECOMB's Approach (2026)
At RECOMB Hair Transplant Centre, Surat, PRP session numbers are prescribed based on the individual patient's diagnosis, stage, concurrent treatment plan, and assessed biological response. Dr. Krishna Bhalala and Dr. Nilesh Kachhadiya do not apply a standard package protocol to all patients.
Trichoscopy is performed before the PRP course begins and repeated after the initial course to assess the clinical response. The decision to continue, adjust frequency, switch to GFC if response is inadequate, or extend maintenance intervals is made based on this assessment rather than on a predetermined commercial schedule.
Patients who are not responding adequately to PRP after a properly conducted initial course are told this directly, and the treatment plan is adjusted accordingly. Continuing a treatment that is not producing measurable benefit is not in the patient's interest regardless of how many sessions remain in a prepaid package.
Get a PRP Plan Based on Your Clinical Response, Not a Package →
WhatsApp: +91 7624008000 | www.recombhair.com
Final Takeaway
The right number of PRP sessions for hair loss in India is not three, not six, and not twelve as a universal answer. It is the number that produces and sustains a measurable clinical response in a specific patient with a specific diagnosis, assessed through trichoscopy at the end of the initial course and adjusted based on what the scalp actually shows.
Patients who receive PRP as a package without a pre-treatment trichoscopy baseline, without assessment of their response after the initial course, and without a clear clinical rationale for the specific session number they have been given are receiving a commercial service rather than a clinical one.
Dr. Krishna Bhalala and Dr. Nilesh Kachhadiya conduct a limited number of personal consultations each week at RECOMB, Surat. If you are on a PRP course and want to know whether the number of sessions you have been given is appropriate for your specific clinical situation, this is where that question gets an honest answer.
Find Out If Your PRP Plan Is Actually Working for Your Hair Loss →
WhatsApp: +91 7624008000
We respond within 24 hours, 6 days a week.
www.recombhair.com
Contact RECOMB Hair Transplant Centre
